The initial public offering (IPO) of Claris Lifesciences Ltd has been subscribed 0.50 times so far. The IPO received bids for 5,390,484 shares against the issue size of 10,789,474 shares on offer.
The high networth individual (HNIs) category as well as the retail portion were subscribed more than once, while qualified institutional bidders (QIB) have not evinced much interest in the IPO so far.
The IPO had been extended till December 2, that is, today as the public issue received a lukewarm response amid a steep fall in the market following the bribes-for-loans scam that came to light last week. Furthermore, Claris also revised its IPO price band to Rs 223 to Rs 248 from Rs 278 to Rs 293 earlier.
The book running lead managers to the issue are Enam Securities, Edelweiss Capital, JM Financial and ICICI Securities.
